Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
06/2005
06/14/2005US6905688 Comprises therapeutic fusion proteins for diagnosis and treatment of cancers, neovascularization and autoimmune diseases
06/14/2005CA2420576C Immunoregulatory compounds, derivatives thereof and their use
06/14/2005CA2304967C 4(3)substituted-4(3)-aminomethyl-(thio)pyran or -piperidine derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders
06/14/2005CA2234096C 1-(1,2-disubstituted piperidinyl)-4-substituted piperazine derivatives
06/09/2005WO2005051912A1 Piperidine compound and method for producing same
06/09/2005WO2005051425A1 Procaspase 1 activation inhibitor
06/09/2005WO2005000403A3 Compositions and methods for treating and preventing heart tissue degeneration, and uses thereof
06/09/2005WO2004105737A3 Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions using various agents
06/09/2005WO2004012671A3 Substituted furo [2,3-b] pyridine derivatives
06/09/2005US20050124795 DNA encoding a human subunit 5-HT3-C of the 5-HT3 serotonin receptor
06/09/2005US20050124793 Novel proteins and dnas thereof
06/09/2005US20050124691 Alpha-aryl-N-alkylnitrones and pharmaceutical compositions containing the same
06/09/2005US20050124689 Tocopherol enriched compositions and amelioration of inflammatory symptoms
06/09/2005US20050124682 Such as N-{2-[5-(methylthio)-1H-indol-3-yl]ethyl}acetamide for treatment of disorders of the melatoninergic system; hormone replacement therapy
06/09/2005US20050124672 Antineoplastic agents, analgesics, antipyretics; prostaglandin E2 receptor antagonists; 3-Methyl-4-[6-[N-isobutyl-N-(2-thiazolylsulfonyl)amino]indan-5-yloxymethyl]benzoic acid, a C1-4 alkyl ester, or a non-toxic salt
06/09/2005US20050124649 Deazapurines and uses thereof
06/09/2005US20050124621 Novel inhibitors of kinases
06/09/2005US20050124609 Orally administering to a patient a methylol transfer agent; e.g., an oral dose of about 100-1000 mg. of taurolidine, taurultam or mixtures; ulcerative colitis; Crohn's disease; reduces side effects when administered with other drugs; synergistic; bactericides; endotoxins; antiinflammatory agents
06/09/2005US20050124605 E.g., substituted 2,3,5,10b-tetraaza-benzo[e]azulen-6-yl)-acetic acids, 2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepin-5-yl)-(4,6-dimethoxy-pyrimidin-2-yloxy)-acetic acids and 2,3,4,5-tetrahydro-benzo[e][1,4]diazepin-1-ylmethyl}-benzoates; treating circulatory, inflammatory, and proliferative disorders
06/09/2005US20050124603 Heterocyclylindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligands
06/09/2005US20050124577 8-Azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient
06/09/2005US20050124574 Purine derivatives
06/09/2005US20050124554 Spermidine derivatives for the treatment of chronic neurodegenerative diseases
06/09/2005US20050124543 Heterologous polypeptide of the TNF family
06/09/2005US20050124538 for prophylaxis, prevention, treatment or therapy of inflammatory conditions or allergic reactions in a mammal; binds bacterial lipopeptide
06/09/2005US20050124537 Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
06/09/2005US20050124532 Using nucleoside, or prodrug thereof
06/09/2005US20050124004 Histamine receptor h3 polynucleotides
06/09/2005US20050124003 Using immunoaffinity selection to isolate and propagate pluripotent stem cell populations from fetal developmental tissues; cell replacement therapies
06/09/2005US20050123912 Nucleoprotein for use as tool in treatment, diagnosis and prevention of infection, cell proliferative, neurological, developmental, autoimmune and inflammatory disorders
06/09/2005US20050123910 Nucleotide sequences coding prolyl oligopeptidase (DPP10) for use in identifying modulator which prevent and treat allergies, asthma, skin and inflammatory diseases
06/09/2005US20050123897 Controlling flux of penetrants across adaptable, semipermeable porous barrier by enlarging applied dose per area; drug delivery kits, patches
06/09/2005US20050123605 Anticancer agents; prevent forming blood vessels; removal blockage
06/09/2005US20050123536 Treatment of immunological disorders using anti-dc30 antibodies
06/09/2005US20050123523 Immunostimulatory nucleic acid molecules
06/09/2005DE4142157B4 Opioid-Peptide, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzung Opioid peptides, process for their preparation and pharmaceutical composition containing the
06/09/2005DE102004054133A1 Silymarin-based food supplement for improving diet and reducing the risk of diseases of civilization, e.g. diabetes, contains a standardized flavonolignan fraction from Marian thistle and a dried Yacon root preparation
06/09/2005CA2814523A1 Colonic purgative composition with soluble binding agent
06/09/2005CA2547467A1 Piperidine compound and method for producing same
06/09/2005CA2547427A1 Composition having liver function protective effect
06/09/2005CA2547398A1 Oral benzimidazole compositions comprising an active core, an optional separating layer and an enteric coating
06/09/2005CA2546637A1 Colonic purgative composition with soluble binding agent
06/08/2005EP1538198A2 Lactic acid bacteria and their cellular components inducing immunoregulatory function, and method of obtaining the same
06/08/2005EP1538162A2 Compositions for altering mucus secretion
06/08/2005EP1538160A1 Substituted Isoquinolin-3-carboxyamides, their preparation and medical use
06/08/2005EP1537870A2 Methods and compositions for treating cancer
06/08/2005EP1537417A2 Method of diagnosing colon and gastric cancers
06/08/2005EP1537206A2 Infectious hepacivirus pseudo-particles containing functional e1, e2 envelope proteins
06/08/2005EP1537138A2 Receptors and membrane-associated proteins
06/08/2005EP1537096A2 Derivatives of dioxane-2-alkyl carbamates, preparation method thereof and application of same in therapeutics
06/08/2005EP1537090A1 Chromone derivatives as matrix metalloproteinase inhibitors
06/08/2005EP1537086A2 Novel phenanthridines
06/08/2005EP1537075A2 Diarylurea derivatives and their use as chloride channel blockers
06/08/2005EP1537074A1 Cathepsin cysteine protease inhibitors
06/08/2005EP1537069A2 ANALOGUES OF LIPID MEDIATORS DERIVED FROM OMEGA-3 PUFAs AND METHODS OF USE
06/08/2005EP1536839A2 Method for treating diseases with omega interferon
06/08/2005EP1536835A1 Liquid formulations with high concentration of human growth hormone (hgh) comprising phenol
06/08/2005EP1536813A2 Compositions and methods comprising protein activated receptor antagonists
06/08/2005EP1536806A1 Use of hesperidin or one of its derivatives for making a medicine for bone formation stimulation
06/08/2005EP1536804A2 2'-c-methyl-3'-o-l-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections
06/08/2005EP1536801A2 Topical compositions and methods for treatment of adverse effects of ionizing radiation
06/08/2005EP1536797A1 1-amido-4-phenyl-4-benzyloxymethyl-piperidine derivatives and related comounds as neurokinin-1 (nk-1) antagonsists for the treatment of emesis, depression, anxiety and cough
06/08/2005EP1465854A4 Chalcone derivatives and their use to treat diseases
06/08/2005EP1373269B1 Jun kinase inhibitors
06/08/2005EP1373231B1 3-heterocyclyl-propano-hydroxamic acid as pcp inhibitors
06/08/2005EP1309575B1 Biphenyl derivatives and their use as ppar-gamma receptor activators
06/08/2005EP1259514B1 3-(pyrolyllactone)-2-indolinone compounds as kinase inhibitors
06/08/2005EP1252133B1 Pharmaceutical compounds
06/08/2005EP1220831B1 Biaryl ether derivatives useful as monoamine reuptake inhibitors
06/08/2005EP1176146B1 Carbamoyl tetrahydropyridine derivatives
06/08/2005EP1054642A4 Light-activated tooth whitening composition and method of using same
06/08/2005EP0849256B1 Amide compounds and use of the same
06/08/2005CN1625603A Genetic polymorphisms in the preprotachykinin gene
06/08/2005CN1625565A Antibodies to non-functional P2X7 receptor, diagnosis and treatment of cancers and other conditions
06/08/2005CN1625558A Aza-arylpiperazines
06/08/2005CN1625557A Fluorenecarboxylic acid esters, process for the manufacture thereof, and use thereof as medicaments
06/08/2005CN1625556A Anticholinergics, processes for the preparation thereof, and pharmaceutical compositions
06/08/2005CN1625554A Amides of aminoalkyl substituted azetidines, pyrrolidines, piperidines and azepanes
06/08/2005CN1625549A Metabolites of (3-[[4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic acid
06/08/2005CN1625422A Synergistic cocomposition of trans-24-15-carbonyl acid and apocynin and its application
06/08/2005CN1625411A Combination of a NSAID and a PDE-4 inhibitor
06/08/2005CN1625400A 2, 4-pyrimidinediamine compounds and their uses
06/08/2005CN1625399A Pharmaceutical composition for regeneration of cirrhotic liver
06/08/2005CN1625346A Powder of amino acids and method for producing the same
06/08/2005CN1625345A Vital cell preparations containing lactic acid bacterium as the ative ingredient and food containing lactic acid
06/08/2005CN1623984A Fused-ring compounds and use thereof as drugs
06/08/2005CN1623599A Xiaoyao soft capsule and its preparation technology
06/08/2005CN1623593A Solid instant preparation extracted from ginkgo leaf and its preparing process
06/08/2005CN1623591A Composition of pharmaceutical and preparation process thereof
06/08/2005CN1623586A Oral anti-inflammation spray and its preparation method
06/08/2005CN1623563A Traditional Chinese medicinal compocition for treating pancreatitis, cholecystitis, appendicitis and acute and chronic gastro enteritis
06/08/2005CN1623547A Medical use of artificial lywrine
06/08/2005CN1623545A Glasqiong hydrochloride oral disintegrating tablet and its preparation method
06/08/2005CN1623539A Milk thistle silybum marianum long effect preparation and its preparation method
06/08/2005CN1205210C 9-azabicyclo (3,3,1) non-2-ene and nonane derivatives as cholinergic ligands at nicotinic ACH receptors
06/08/2005CN1205188C 4,5-dihydro-1h-pyrazole derivatives having CB1-antagonistic activity
06/08/2005CN1205181C Matrix metalloproteinase inhibitors
06/08/2005CN1204906C Medicine for curing hepatitis B and preparation method thereof
06/08/2005CN1204905C Medicine for curing hepatitis B and production method thereof
06/08/2005CN1204903C Chinese medicine for treating gastropathy and its prepn. process
1 ... 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 ... 1258